Hadassah Medical Center-Oncology ( Site 1303)
Hadassah Medical Center-Oncology ( Site 1303)
Jerusalem, Israel1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016) | neoplasm | Active, not recruiting | Phase 2 | 2025-04-06 | NCT04976634 |